PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Oral administration of Byrsoninas A and B (20 mg/kg/day for 30 days) in mice reduced blood glucose, cholesterol, triglycerides, and lipoprotein levels while increasing HDL-cholesterol and antioxidant enzymes [PMID:30263386]
A methanolic extract of B. crassifolia produced significant antidepressant effects in ICR mice [PMID:21788126]
B. crassifolia extract exhibited synergism with three antibiotics against this multidrug-resistant strain in vitro [PMID:32981476]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 30007736 (2018) — Carotenoids and xanthophyll esters of yellow and red nance fruits (Byrsonima crassifolia (L.) Kunth) from Costa Rica. · Food research international (Ottawa, Ont.)
- 2.PMID: 8134422 (1994) — A new glycolipid from Byrsonima crassifolia. · Planta medica
- 3.PMID: 30263386 (2016) — Hypoglycemic Effects of sesquiterpene lactones from Byrsonima crassifolia. · Food science and biotechnology
- 4.PMID: 21788126 (2011) — Antidepressant effect and pharmacological evaluation of standardized extract of flavonoids from Byrsonima crassifolia. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 5.PMID: 27813596 (2016) — Genetic variability analysis of Byrsonima crassifolia germplasm collected in Pará State using ISSR markers.